Step Two Corporation Fund Raise of ₹4 Cr

Step Two Corporation Board Meeting Date

Step Two Corporation will hold a board meeting on 3 November 2026 to consider unaudited quarterly results. The intimation discloses no financial figures.

Step Two Corporation Other Announcement

Step Two Corporation Ltd has filed its quarterly shareholding pattern for the period ending September 30, 2026, in compliance with SEBI Listing Regulations.

Step Two Corporation Annual General Meeting

Step Two Corporation Ltd's AGM passed all five resolutions, including FY26 financials adoption and a preferential equity issue. Voting was 99.99% favourable across all resolutions.

Step Two Corporation Annual General Meeting

Step Two Corporation Limited concluded its 32nd Annual General Meeting on September 28, 2026. Members passed all items including accounts adoption and authorized capital increase.

Step Two Corporation Capital Structure Change

Step Two Corporation Ltd board approved increasing authorized share capital from Rs. 7.85 Crore to Rs. 12 Crore. The increase supports a planned fund raise via preferential issue.

Step Two Corporation Board Meeting Date

Step Two Corporation has scheduled a Board Meeting for September 02, 2026, to consider proposals for raising funds through various securities instruments.

Rite Zone Chemcon India Fund Raise of ₹6.58 Cr

Rite Zone Chemcon India announced a preferential issue of 27,69,730 equity shares to 11 investors at Rs.24 each, raising about Rs.6.58 Crore. The approval awaits a shareholder vote on 23 November 2026.

Value

₹6.58 Cr

Sudarshan Pharma Industries Fund Raise of ₹72 Cr

Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.

Value

₹72.00 Cr

Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr

Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.

Value

₹68.20 Cr

Kanel Industries Fund Raise of ₹16.99 Cr

Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.

Value

₹16.99 Cr

Execution

Rights issue opens 23 November 2026 and closes 30 November 2026

Sudarshan Pharma Industries Fund Raise

Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.

GAIL (India) Fund Raise

GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.